Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUPGF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,731
Award facts
- Contract value 100% obligated
- $56,730.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,730.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pen injectors on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems.
As a critical vendor in the Defense Health Agency's medical supply chain, AmerisourceBergen leverages its comprehensive IDC vehicle to supply pharmaceutical products and medical commodities to military and veteran healthcare programs globally. This delivery order for Dupixent, a biologic used to treat conditions such as atopic dermatitis and asthma, reflects the company's ongoing role in fulfilling specialized pharmaceutical needs across the Department of Defense healthcare enterprise. The firm fixed-price structure and rapid completion timeline are consistent with AmerisourceBergen's typical delivery order execution patterns, supporting the agency's requirement to maintain adequate pharmaceutical inventory for beneficiaries across the military health system.
Quick answers
Who was awarded contract SPE2DB25FUPGF?
SPE2DB25FUPGF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FUPGF worth?
The government has obligated $56,731 on SPE2DB25FUPGF.
Is contract SPE2DB25FUPGF an order under another contract?
Yes. SPE2DB25FUPGF is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUPGF competed?
The extent of competition for SPE2DB25FUPGF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award